Literature DB >> 8522348

Novel monoclonal antibody reactive with thrombin-sensitive 74-kDa glycoproteins present on platelets and megakaryocytes both from mouse and rat.

K Takada1, M Saito, H Kaneko, K Iizuka, Y Kokai, J Fujimoto.   

Abstract

A monoclonal antibody (designated 1C2) that reacts only with mouse platelets and megakaryocytes among hematopoietic cells was established by immunizing mouse platelets to an Armenian hamster. 1C2 reactive mouse molecule (1C2 antigen) was a surface glycoprotein with molecular weight of 74 kDa. Side by side comparison revealed that 4A5, a rat monoclonal antibody against mouse platelet, immunoprecipitated the identical molecule to 1C2 antigen. Of particular interest, 1C2 also labeled rat tissues with an identical pattern to that of mouse tissues and recognized a 74-kDa protein from rat platelets. Reactivity of 1C2 to mouse and rat platelets decreased when they were treated with thrombin. Following thrombin treatment of mouse platelets, 1C2 reactive 69-kDa protein appeared in the supernatants. Mouse and rat 1C2 antigens purified on 1C2-coated beads were cleaved by thrombin to generate 69-kDa fragments, establishing that 1C2 antigen is a direct substrate for thrombin. 1C2 is the first antibody to platelets and megakaryocytes of mouse and rat whose reactive molecule is well characterized, i.e., substrate for thrombin. 1C2 can be a useful tool in studying megakaryocytopoiesis and thrombopoiesis in rodent systems.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8522348     DOI: 10.1089/hyb.1995.14.361

Source DB:  PubMed          Journal:  Hybridoma        ISSN: 0272-457X


  3 in total

1.  GATA-2 and GATA-2/ER display opposing activities in the development and differentiation of blood progenitors.

Authors:  Kenji Kitajima; Masaaki Masuhara; Takumi Era; Tariq Enver; Toru Nakano
Journal:  EMBO J       Date:  2002-06-17       Impact factor: 11.598

2.  Multipotential differentiation ability of GATA-1-null erythroid-committed cells.

Authors:  Kenji Kitajima; Jie Zheng; Hilo Yen; Daijiro Sugiyama; Toru Nakano
Journal:  Genes Dev       Date:  2006-03-15       Impact factor: 11.361

3.  An expandable, inducible hemangioblast state regulated by fibroblast growth factor.

Authors:  David T Vereide; Vernella Vickerman; Scott A Swanson; Li-Fang Chu; Brian E McIntosh; James A Thomson
Journal:  Stem Cell Reports       Date:  2014-11-13       Impact factor: 7.765

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.